Stocks to Watch: Akari Therapeutics, BlackSky Technology

Dow Jones05-23 06:35
 

By Katherine Hamilton

 

Akari Therapeutics said it entered a securities purchase agreement for a private placement. The stock dropped 26% to $13.48 in after-hours trading Friday.

BlackSky Technology entered a sales agreement to offer and sell up to $250 million of Class A stock. Shares declined 3% to $46.49 after closing up 7%.

 

Write to Katherine Hamilton at katherine.hamilton@wsj.com

 

(END) Dow Jones Newswires

May 22, 2026 18:35 ET (22:35 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment